知镜 Cognispect · 医学文献与研究工作台

PET for Evaluation of Neurologic Diseases: Part one: Neurodegenerative Diseases.

Veziroglu E, Nikpanah M, Farhadi F, Kalbi D, Hensley C, McConathy J.
Radiologic clinics of North America · 2026-11-01 · PMID 42957394

文献摘要

This review of PET for evaluation of neurological diseases is divided into two parts; part one examines the clinical use of positron emission tomography (PET) in neurodegenerative diseases. FDG-PET can identify characteristic patterns of cerebral metabolism and help distinguish among neurodegenerative disorders. Amyloid and tau PET have expanding diagnostic and theranostic roles in Alzheimer's disease, including assessment of disease-specific pathology and treatment eligibility. FDOPA-PET evaluates presynaptic dopamine synthesis and supports assessment of Parkinson's disease and other parkinsonian syndromes. Combined with structural imaging and clinical evaluation, PET can improve diagnostic confidence, refine prognosis, and inform treatment decisions.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。